Related Experiment Videos
Etiology of osteosarcoma
Bruno Fuchs1, Douglas J Pritchard
1Mayo Clinic, Department of Orthopedics, Rochester, MN 55905, USA.
Abstract:
Although the prognosis and quality of life of patients with osteosarcoma were improved significantly during the past decades, the pathogenesis and etiology of this disease remain obscure. Significant interest and effort in this cancer led to the identification of numerous etiologic agents. Several chemical agents such as beryllium, viruses such as FBJ, subsequently found to contain the src-oncogene, and radiation were shown to be potent inducers of osteosarcoma. Paget's disease, electrical burn, or trauma all are thought to be other factors that may contribute to the pathogenesis. More recently, patients with hereditary diseases such as Rothmund-Thomson syndrome, Bloom syndrome, and Li-Fraumeni syndrome were found to have an increased risk of having osteosarcoma develop. During the past few years, the molecular analysis brought a wealth of new information with numerous genes that were associated with osteosarcoma and its clinical disease progression. They can be categorized into self-sufficiency in growth signals, insensitivity to growth inhibitory signals, evasion of apoptosis, limitless replicative potential, sustained angiogenesis, and tissue evasion and metastasis. Although the understanding of these processes in osteosarcoma still is incomplete, it may have the potential to significantly affect the patient care in the future.
Insights
Osteosarcoma pathogenesis remains unclear despite improved patient outcomes. Research identifies chemical agents, viruses, radiation, and genetic factors contributing to osteosarcoma development and progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma prognosis has improved, yet its origins and causes are not fully understood.
- Previous research identified chemical agents, viruses (e.g., FBJ), radiation, Paget's disease, trauma, and hereditary syndromes as potential contributors.
- Recent molecular analyses have revealed numerous genes linked to osteosarcoma and its progression.
Purpose of the Study:
- To review the current understanding of osteosarcoma pathogenesis and etiology.
- To highlight the molecular mechanisms underlying osteosarcoma development and progression.
- To discuss the potential impact of this knowledge on future patient care.
Main Methods:
- Literature review of established and emerging etiologic factors for osteosarcoma.
- Analysis of molecular mechanisms implicated in osteosarcoma, including gene associations.
- Categorization of molecular pathways involved in cancer progression.
Main Results:
- Identified various etiologic agents: chemical (beryllium), viral (FBJ), radiation, Paget's disease, trauma, and hereditary syndromes (Rothmund-Thomson, Bloom, Li-Fraumeni).
- Molecular analysis revealed key cancer hallmarks associated with osteosarcoma: self-sufficiency in growth signals, insensitivity to inhibition, apoptosis evasion, replicative potential, angiogenesis, and metastasis.
- Numerous genes have been linked to osteosarcoma and its clinical progression.
Conclusions:
- While significant progress has been made, the complete pathogenesis and etiology of osteosarcoma require further investigation.
- Understanding the molecular underpinnings of osteosarcoma offers potential for improved future patient management and therapeutic strategies.